Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Gross Margin: 2013-2020

Historic Gross Margin for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2020 value amounting to 99.23%.

  • Ironwood Pharmaceuticals' Gross Margin rose 795.00% to 99.23% in Q4 2020 from the same period last year, while for Dec 2020 it was 87.46%, marking a year-over-year decrease of 530.00%. This contributed to the annual value of 99.19% for FY2020, which is 477.00% up from last year.
  • According to the latest figures from Q4 2020, Ironwood Pharmaceuticals' Gross Margin is 99.23%, which was up 2.09% from 97.20% recorded in Q1 2020.
  • In the past 5 years, Ironwood Pharmaceuticals' Gross Margin ranged from a high of 99.23% in Q4 2020 and a low of 83.58% during Q4 2018.
  • For the 3-year period, Ironwood Pharmaceuticals' Gross Margin averaged around 94.06%, with its median value being 95.61% (2018).
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by 689bps in 2018, then skyrocketed by 795bps in 2020.
  • Over the past 4 years, Ironwood Pharmaceuticals' Gross Margin (Quarterly) stood at 90.46% in 2017, then tumbled by 689bps to 83.58% in 2018, then skyrocketed by 770bps to 91.28% in 2019, then spiked by 795bps to 99.23% in 2020.
  • Its last three reported values are 99.23% in Q4 2020, 97.20% for Q1 2020, and 91.28% during Q4 2019.